Iowa SF56 amends the right to try Act to expand eligibility for investigational treatments and clarify manufacturer and facility rights.

Iowa SF56 amends the right to try Act to expand eligibility for investigational treatments. The bill defines "eligible patient" to include those with a terminal illness or a life-threatening or severely debilitating illness who have considered and rejected all other FDA-approved treatment options. It also applies the Code chapter to "individualized investigational treatments," which are unique to an individual patient based on their genetic profile.

Iowa SF56 amends the right to try Act to expand eligibility for investigational treatments and clarify manufacturer and facility rights.

Iowa SF56 amends the right to try Act to expand eligibility for investigational treatments. The bill defines "eligible patient" to include those with a terminal illness or a life-threatening or severely debilitating illness who have considered and rejected all other FDA-approved treatment options. It also applies the Code chapter to "individualized investigational treatments," which are unique to an individual patient based on their genetic profile.